Lab Blogs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Building Universal Data Accessibility: The Real Foundation of a Lab AI Strategy
Every leader wants to talk about AI. Fewer want to talk about what has to happen before AI can be applied. Most labs aren’t ready to “do AI” in any meaningful way – not because the models aren’t good enough, but because the data those models would need is scattered, siloed, poorly contextualised, and locked inside proprietary formats. If you want to play the AI end game, you first have to build the foundation underneath it: universal data accessibility.

How can data management software reduce drug candidate identification timelines?
The mass spectrometry (MS) data systems market reached USD $413M in 2023, with growth forecasted to reach USD $560M by 2028. (1) This expansion is driven primarily by the growth of the pharmaceutical and biopharmaceutical industries, public and environmental health concerns, growing government investment, and the integration of artificial intelligence (AI). (2)

£750,000 funding supports next-generation plant science infrastructure
Oak Foundation funding will support a 3,900m² research facility, enabling controlled climate studies of plant, microbial and insect interactions for more resilient agriculture.

AI and funding accelerate UK life-science innovation
AI-enabled biosensor workflows and new regional funding are helping UK life-science teams accelerate discovery, prototype health technologies and progress promising products towards real-world application.

Kent climate-tech start-ups move into specialist laboratory space
Discovery Park has welcomed two climate-tech start-ups developing PFAS remediation and conductive materials, demonstrating how specialist laboratories can help translate sustainability research into practical tech.

GSK and Oxford University launch multi-omics ulcerative colitis trial
GSK and Oxford University’s £10 million PEGASUS trial combines single-cell RNA analysis, spatial transcriptomics and proteomics to investigate new treatment approaches for ulcerative colitis and map biological responses over time.

Newborn genome study advances early rare-condition detection
The Generation Study is exploring how whole-genome sequencing could support earlier detection of rare, treatable conditions in newborns, before symptoms appear.

Direct genetic testing expands access to breast cancer care
Step into the future of biomedical science with the University of Essex’s new £3 million BioSTAR-Lab, where cutting-edge research meets hands-on training. Discover how this state-of-the-art facility is shaping the next generation of scientists ready to revolutionize healthcare and innovation.

£3.52 billion campus to strengthen UK biosecurity
Britain’s £3.52 billion Health Security Campus will unite 2,500 specialists by 2038, creating advanced containment laboratories for infectious-disease research and preparedness.

Connected laboratories drive the next phase of digital transformation
Digital transformation continues to reshape how laboratories manage data, connect instruments and deliver reliable results. As demand grows for greater efficiency, traceability and compliance, laboratories are increasingly moving from standalone software towards connected, cloud-based platforms.

£4 million consortium advances mRNA vaccines for livestock health
A new £4 million research consortium, led by The Pirbright Institute, is developing next-generation vaccine technologies to improve livestock disease control and help reduce antimicrobial resistance.

Extreme-environment labs expand testing capability
New facilities and research partnerships are expanding the ability of laboratories to test performance, materials and measurement systems under extreme conditions.